Danske Bank’s United Therapeutics UTHR Stock Holding History

Danske Bank’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.1M	Buy	18,709 +360	+2%	+$186K	0.02%	440
2026 Q2	$9.9M	Buy	18,349 +1,320	+8%	+$743K	0.02%	457
2026 Q1	$10.1M	Sell	17,029 -2,444	-13%	-$1.22M	0.02%	429
2025 Q4	$9.49M	Buy	19,473 +3,484	+22%	+$1.62M	0.02%	452
2025 Q3	$6.7M	Sell	15,989 -17,192	-52%	-$5.78M	0.02%	494
2025 Q2	$9.5M	Sell	33,181 -26,103	-44%	-$7.8M	0.02%	435
2025 Q1	$18.3M	Sell	59,284 -9,923	-14%	-$3.4M	0.06%	289
2024 Q4	$24.4M	Sell	69,207 -26,236	-27%	-$9.6M	0.07%	239
2024 Q3	$34.2M	Sell	95,443 -31,679	-25%	-$10.7M	0.11%	162
2024 Q2	$40.5M	Buy	127,122 +31,607	+33%	+$8.37M	0.15%	121
2024 Q1	$21.9M	Buy	+95,515	New	+$21.6M	0.07%	249

Other funds holding UTHR

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Danske Bank's UTHR Position: Q3 2026 in Review

Danske Bank increased its United Therapeutics (UTHR) stake by 2% in Q3 2026, buying an estimated $186K and bringing the position to 18,709 shares worth $10.1M. The position accounts for 0.02% of the portfolio, ranked #440.

Danske Bank first reported a position in UTHR in Q1 2024 and has held it in 11 quarters since. The position peaked at $40.5M in Q2 2024. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Danske Bank held 18,709 shares of United Therapeutics worth $10.1M as of Q3 2026.
Danske Bank bought 360 United Therapeutics shares in Q3 2026, an estimated $186K.
United Therapeutics made up 0.02% of Danske Bank's portfolio in Q3 2026, its #440 holding.
Danske Bank first reported a position in United Therapeutics in Q1 2024 and has held it in 11 quarters since.
Danske Bank's United Therapeutics position peaked at $40.5M in Q2 2024.
673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.